Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Scientific Reports|July 31, 2021
A neural pathomics framework for classifying colorectal cancer histopathology images based on wavelet multi-scale texture analysisEleftherios Trivizakis, Georgios S Ioannidis, Ioannis Souglakos, et al.
International Journal of Oncology|May 30, 2020
Artificial intelligence radiogenomics for advancing precision and effectiveness in oncologic care (Review)Eleftherios Trivizakis, Georgios Z Papadakis, Ioannis Souglakos, et al.
Annals of Gastroenterology|January 2, 2020
Brain and bone marrow metastases from rectal cancerKonstantina Thomopoulou, Stavroula Manolakou, Ippokratis Messaritakis, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|January 25, 2021
A feasibility study of circulating melanoma cells in the perioperative context of hyperthermic isolated limb perfusion (HILP) in 20 patientsDimosthenis Michelakis, Konstantinos Lasithiotakis, Ippokratis Messaritakis, et al.
Forum of Clinical Oncology|March 19, 2016
Projecting Event-Based Analysis Dates in Clinical Trials: An Illustration Based on the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) Collaboration. Projecting analysis dates for the IDEA collaborationLindsay A Renfro, Axel M Grothey, James Paul, et al.
European Journal of Cancer (Oxford, England : 1990)|September 6, 2020
A new prognostic and predictive tool for shared decision making in stage III colon cancerAlberto F Sobrero, Alberto Puccini, Qian Shi, et al.
Current Colorectal Cancer Reports|September 14, 2013
The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current StatusThierry André, Timothy Iveson, Roberto Labianca, et al.
Biomedicines|May 27, 2023
RETRO-TAS, a Retrospective Observational Study of Trifluridine/Tipiracil in Chemorefractory Metastatic Colorectal CancerAnna Koumarianou, Anastasios Ntavatzikos, David Symeonidis, et al.
The Lancet. Oncology|December 3, 2020
Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trialsThierry André, Jeffrey Meyerhardt, Timothy Iveson, et al.
Clinical Colorectal Cancer|July 8, 2018
AMALTHEA: Prospective, Single-Arm Study of the Hellenic Cooperative Oncology Group (HeCOG) Evaluating Efficacy and Safety of First-Line FOLFIRI + Aflibercept for 6 Months Followed by Aflibercept Maintenance in Patients With Metastatic Colorectal CancerGeorge Pentheroudakis, Vassiliki Kotoula, Georgia-Angeliki Koliou, et al.
Pageof 2